Skip to main content
FRMM
NASDAQ Crypto Assets

Forum Markets Reduces Share Buyback Authorization by $150M, Extends Program

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$5.44
Mkt Cap
$84.058M
52W Low
$1.76
52W High
$174.6
52W Position info
209% above low
Off High info
97% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

FRMM has more than doubled off its 52-week low of $1.76 on light trading volume (0.2× avg).

Summary

Forum Markets amended its share repurchase program, extending it by one year but drastically cutting the authorized amount from $250 million to $100 million, signaling reduced capacity for buybacks amidst financial challenges.


Key Events · Financing and Capital Events · FRMM

  • Share Repurchase Program Extended

    The existing share repurchase program, previously set to expire on June 30, 2026, has been extended for an additional year through June 30, 2027.

  • Buyback Authorization Reduced by $150 Million

    The aggregate repurchase authorization was significantly reduced from $250 million to $100 million. This represents a $150 million reduction in potential buyback capacity, which is nearly twice the company's current market capitalization.

  • Expanded Repurchase Methods

    The program now expressly authorizes repurchases through derivative transactions, offering more flexibility in execution.

  • Context of Financial Distress

    This amendment follows a Q1 net loss of $76.26 million (exceeding market cap) and the disclosure of a material weakness in internal controls, alongside an active $500 million at-the-market offering.


Analysis · FRMM · Crypto Assets

The company significantly reduced the authorized amount for its share repurchase program from $250 million to $100 million, a substantial cut given its $84.06 million market capitalization. While the program was extended for another year and expanded to include derivative transactions, the reduction in buyback capacity is a negative signal, especially considering the company's recent massive Q1 loss and the existence of a $500 million at-the-market offering. This suggests a more constrained financial outlook or a reprioritization of capital away from share repurchases.

At the time of this filing, FRMM was trading at $5.44 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $84.1M. The 52-week trading range was $1.76 to $174.60. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

FRMM - Latest Insights

FRMM
Aug 13, 2026, 8:17 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $5.81
Real-time Price: $6.08 info
Change: +$0.270 (+5%) info
Market Cap: $80.318M info
FRMM
Jul 16, 2026, 8:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $5.90
Real-time Price: $6.08 info
Change: +$0.180 (+3%) info
Market Cap: $80.318M info
FRMM
Jul 16, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $5.99
Real-time Price: $6.08 info
Change: +$0.090 (+2%) info
Market Cap: $80.318M info
FRMM
Jul 08, 2026, 4:11 PM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $5.96
Real-time Price: $6.08 info
Change: +$0.120 (+2%) info
Market Cap: $80.318M info
FRMM
Jul 01, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.57
Real-time Price: $6.08 info
Change: +$0.510 (+9%) info
Market Cap: $80.318M info